vendredi 31 mars 2017

Onco Actu du 31 mars 2017

1. Biologie

Mass. General/Broad Institute study charts single-cell composition of two major types of brain tumor [Mass. General Hospital]

3. Prévention

Carrots and pumpkin might reduce your risk of cancer, but beware taking them in pill form [The Conversation]

Vitamin D & cancer: How can two news releases about the same study be polar opposites? [HealthNewsReview]

3.8 Prévention - Alimentation

Recommendations set out for food industry to reduce sugar [Cancer Research UK]

4. Dépistage, diagnostic et pronostic

Cancer: Imaging with antibodies [Nature]

5. Traitements

Blinatumomab Extends Survival for Patients with Advanced ALL [NCI]

5.12 Immunothérapies

Previously elusive targets for cancer immunotherapy identified [Stanford Medicine]

5.12.1 Immunothérapies - partenariats

Bristol-Myers Squibb Enters Collaboration to Leverage Foundation Medicine’s Molecular Information Platform to Identify Predictive Biomarkers Across Multiple Tumor Types and Immunotherapy Agents [BMS]

5.12.2 Immunothérapies - CAR-T

Fresh turmoil inside Novartis’ revamped CAR-T organization as top exec jumps ship [EndPoints]

5.2 Pharma

Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself [Xconomy]

5.2.1 Pharma - Partenariats

Phase II Study of Daratumumab in Non-Hodgkin's Lymphoma Will Not Proceed to Stage 2 of Trial [Genmab]

5.3 Traitements - FDA, EMA, NICE...

Trump's FDA choice Gottlieb offers solution to conflict-of-interest claims [FierceBiotech]

5.9 AACR

Seattle Genetics Highlights Leadership in Antibody-Drug Conjugate Technology Innovation at the American Association for Cancer Research (AACR) Annual Meeting [Seattle Genetics]

Kite to Present Two Plenary Presentations from the ZUMA-1 Pivotal Trial of Axicabtagene Ciloleucel at the 2017 American Association of Cancer Research Annual Meeting [AACR]

Cancer org bestows award on scientist under investigation [Retraction Watch]

6.1 Observation

ASCO Releases Recommendations to Harness Untapped Potential of Observational Research to Inform Decision Making in Cancer Care [ASCO]

U.S. rates of double-mastectomies for breast cancer vary by state [Reuters]

6.10 Politiques

Carl Heneghan: Is Michael Gove right—should the clinical trials directive be scrapped? [BMJ Blogs]

6.10.1 Politiques (USA)

AACR Statement on House Committee on Oversight and Government Reform’s Hearing, “Federally Funded Cancer Research: Coordination and Innovation” [AACR]

Trump Leaves Science Jobs Vacant, Troubling Critics [NY Times]

6.11 Patients

Living With Cancer: The Haves and Have-Nots of Cancer Care [NY Times]

Young cancer patients may lag peers in social functioning for years [Reuters]

6.4 Médico-éco

NIH research grants yield economic windfall [Nature]

Drastic cuts to NIH budget could translate to less innovation and fewer patents, study argues [LA Times]

6.6 Publications

It's not just you: science papers are getting harder to read [Nature]